THOUSAND OAKS, Calif., Jan. 14-- Amgen Inc.
(Nasdaq: AMGN), the world´s largest biotechnology company, today announced
that it would report fourth quarter and full year 2003 financial results on
Thursday, January 22, 2004 after the financial markets close. The
announcement will be followed by a conference call with the investment
community at 2:00 p.m. PST.
Participating in the call from Amgen will be Kevin Sharer, Chairman, Chief
Executive Officer, and President, and other members of Amgen´s senior
Live audio of the conference call will be simultaneously broadcast over
the Internet and will be available to members of the news media, investors and
the general public. The conference call is expected to last approximately one
This event can be accessed by going to Amgen´s Web site, www.amgen.com ,
and clicking on Investors, then on Amgen Events. The event will be archived
and available for replay for 72 hours after the event.
Amgen is a global biotechnology company that discovers, develops,
manufactures and markets important human therapeutics based on advances in
cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks
Sabrina Johnson, (805) 447-4587 (media)
Cary Rosansky, (805) 447-1060 (investors)